Separating myth from fact, this authoritative work reviews the breadth of current knowledge about methamphetamine addiction and describes the most promising available treatment approaches. Leading experts present state-of-the-art information on the effects of methamphetamine on the brain, body, mental health, and behavior. Psychosocial and pharmacological treatment strategies are critically evaluated, including approaches to treating dually diagnosed clients. Written in a concise, accessible style, the volume emphasizes that recovery is possible, despite the significant challenges the drug poses. The authors identify key avenues for collaboration among clinical, public health, and other professionals.

John M. Roll, PhD, is Professor and Associate Dean for Research at Washington State University College of Nursing in Spokane and Director of its Program of Excellence in the Addictions. He is a Fellow of the American Psychological Association, President of the association's Division on Psychopharmacology and Substance Abuse, and was a vice-chairman of the Washington State Governor’s Council on Substance Abuse. Dr. Roll has received research funding from federal, state, and local sources, as well as foundation and industry support.

Richard A. Rawson, PhD, is Associate Director of the UCLA Integrated Substance Abuse Programs, one of the foremost substance abuse research groups, and Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Rawson oversees clinical trials on pharmacological and psychosocial addiction treatments. He served on the Federal Methamphetamine Advisory Group from 1996 to 1999.

Walter Ling, MD, is a board-certified neurologist and psychiatrist, Professor- in-Residence of Psychiatry at the David Geffen School of Medicine at the University of California, Los Angeles, and Director of the UCLA Integrated Substance Abuse Programs. He is a consultant for numerous local, national, and international private and public agencies. Dr. Ling's current research program is designed to bring cutting-edge findings from treatment research to practice in community treatment programs.

Steven Shoptaw, PhD, is Professor of Family Medicine and of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine at the University of California, Los Angeles. Dr. Shoptaw’s research involves developing and implementing efficacious treatments for individuals with various drug dependence problems, particularly for those with stimulant dependence and risks for HIV infection and other health care problems.